| CASE REPORT |
|
| Year : 2020 | Volume
: 24
| Issue : 2 | Page : 133-134 |
|
|
Effectiveness of adalimumab in combination with intense pulsed light and radiofrequency therapy (LAight®) for severe hidradenitis suppurativa: A case report
Uwe Kirschner1, Berenice Maureen Lang2, Kerstin Steinbrink3, Sophia Zimmer2
1 Dermatology Practice, Dr. Uwe Kirschner, Mainz, Germany
2 Department of Dermatology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany
3 Department of Dermatology, University of Münster, Münster, Germany
Correspondence Address:
Dr. Sophia Zimmer
Department of Dermatology, University Medical Center of the Johannes Gutenberg University, Langenbeckstr. 1, 55131 Mainz
Germany
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/jdds.jdds_36_19
|
|
|
Hidradenitis suppurativa (HS also named as acne inversa) is a chronic skin disease characterized by relapsing formation of abscesses, inflammatory nodules, and fistulas. In moderate-to-severe disease, HS leads to the formation of scarring and thus irreversible tissue destruction. In the past few years, two new treatment options became available: adalimumab, the first biologic therapy approved for HS (Humira®, AbbVie), and a noninvasive, device-based treatment utilizing a combination of intense pulsed light and radiofrequency (LAight® therapy, LENICURA, Germany). Here, we report a case of a Hurley stage III patient where the positive effect of adalimumab could be enhanced by simultaneously applying LAight® therapy. Moreover, long-term symptom control could be achieved under monotherapy with LAight® after adalimumab was terminated.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
